drugset / Trial / NCT00591825
fMRI Study Examining Effects of D-cycloserine in Specific Phobia
Phase 2
Completed
54 enrolled
University of Kansas Medical Center
American Psychological Association (APA) · collabAmerican Psychological Foundation · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The research team hopes to use brain imaging and mental testing to learn more about specific phobias and the treatment of phobia. When given directly prior to therapy sessions, D-cycloserine has been shown to enhance the effects of therapy. This study hopes to identify reasons why D-cycloserine has this effect by measuring brain activity.
Timeline
- Start
- 2006-03
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cycloserine | Small molecule | 100 mg | — |